Related Experiment Video
Updated: Aug 2, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[Results of treatment of acute lymphoblastic leukemia over a 12-year period]
E Bubanská1, K Mociková, B Wildová
1Detské oddejenie Krajského ústavu národného zdravia, Banská Bystrica.
Insights
This study reports on 72 children with acute lymphoblastic leukaemia (ALL), achieving a 93% initial complete remission rate. Long-term survival and relapse data are presented for pediatric ALL treatment.
Area of Science:
- Pediatric Oncology
- Hematology
- Clinical Research
Abstract:
In the course of a 12-year period the authors treated at the Paediatric Department of the Regional Institute of National Health in Banská Bystrica 72 children with acute lymphoblastic leukaemia according to four protocols. Complete remission was achieved by 67 children, i.e. 93%. None of the children died from complications of treatment during complete remission. A relapse during treatment or soon after its termination occurred in 23 children, i.e. 31.9%. A second complete remission was achieved in 15 children, i.e. 65.2%. During the second complete remission seven children survive for 0.5-91.5 months. Twenty children died, i.e. 27.8%. All children had at the time of death signs of malignant disease. Fifty-two children survive at present for 1-132 months. The cumulative ratio of surviving children in the 12th year since the diagnosis is 0.57, the cumulative ratio of children in initial complete remission in the 12th year is 0.51.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025